Related Experiment Video
Updated: Oct 12, 2025

05:30
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
665
Extracellular vesicles: Potential impact on cardiovascular diseases
Jian Yang1, Xue Zou2, Pedro A Jose3
1Department of Clinical Nutrition, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, PR China.
Advances in Clinical Chemistry
|November 23, 2021
Summary
Extracellular vesicles (EVs) are crucial for cell communication and show potential as biomarkers and therapeutics for cardiovascular diseases (CVD). This review explores their role in CVD diagnosis and treatment.
Area of Science:
- Cellular Biology
- Biomedical Research
- Translational Medicine
Background:
- Extracellular vesicles (EVs) mediate intercellular communication and regulate physiological processes like immune response and homeostasis.
- EVs are categorized into exosomes, microvesicles, and apoptotic bodies based on size and origin.
- Altered EV profiles in cardiovascular disease (CVD) suggest diagnostic and prognostic potential.
Purpose of the Study:
- To review the evolving role of EVs in cardiovascular diseases (CVD).
- To summarize EV-mediated regulatory mechanisms in CVD.
- To highlight diagnostic and therapeutic strategies involving EVs for CVD.
Main Methods:
- Literature review of current research on EVs and CVD.
- Analysis of EV functions in normal physiology and cardiovascular pathologies.
- Exploration of EV-based diagnostic and therapeutic applications.
Main Results:
- EVs play significant roles in cellular homeostasis, immune regulation, and intercellular communication.
- Circulating EV alterations are linked to various cardiovascular pathologies.
- EVs show promise as biomarkers for CVD diagnosis and prognosis.
- EVs are being investigated as potential therapeutic agents for CVD.
Conclusions:
- EVs are integral to cell-to-cell communication and have profound implications in cardiovascular health and disease.
- Further research into EV-mediated mechanisms can advance CVD diagnosis and therapy.
- EVs represent a promising frontier in translational medicine for cardiovascular conditions.
Related Concept Videos
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.4K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.4K

